1 / 5

Venous Thromboembolism Treatment Market | Size, Share, Industry Trends, Growth D

A recent report published by Precision Business Insights on Venous Thromboembolism Treatment Market provides in-depth analysis of segments and sub-segments in the global as well as regional.

ramkumarss
Télécharger la présentation

Venous Thromboembolism Treatment Market | Size, Share, Industry Trends, Growth D

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Venous Thromboembolism Treatment Market, (2023-29) 1

  2. Market Overview: The global venous thromboembolism treatment market size was valued at USD 1.32 billion in 2022 and is poised to grow at a significant CAGR of 9.0% during the forecast period 2023-29. The venous thromboembolism treatment market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of the venous thromboembolism treatment market analysis from 2023 to 2029 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description 2

  3. Market Segments: The venous thromboembolism treatment market has been fragmented based on: 1. By Drug Type : Factor Xa inhibitors, Thrombolytic therapy, Plasminogen activators, Fondaparinux, Dabigatran, Warfarin 2. By Disease Type : Deep vein thrombosis, Pulmonary embolism 3. By Distribution Channel : Hospital pharmacies, Online Pharmacies, Retail pharmacies Request Sample Report 3

  4. Key Players: Some of the major key players in the venous thromboembolism treatment market are: • Sanofi (France) • Pfizer Inc. (U.S.) • Daiichi Sankyo Co. Ltd. (Japan) • Bristol Myers Squibb (U.S.) • Johnson & Johnson Services, Inc. (U.S.) • AbbVie Inc. (U.S.) • Merck & Co. (U.S.) • Astellas Pharma Inc. (Japan) • Sawai Pharmaceuticals Co. Ltd. (U.S.) • Abbott Laboratories (U.S.) Request Sample Report 4

  5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553 5

More Related